Company / Interest Expense per Share
Dexcom Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.04
FY2025
5-year range
$0.04 / $0.20
FY2021-FY2025
Trend
-2.6%
vs FY2024
Sector context
#38 of 44
Health Care
What the data says
Dexcom's interest expense per share of $0.04 is lower than 86% of companies in the Health Care sector (FY2025). Interest Expense per Share has declined for 4 consecutive years, from $0.20 in FY2021 to $0.04 in FY2025.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of -27.4%.
Improved from $0.04 to $0.04 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -6.6%
- 5-Year CAGR
- -27.4%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $0.04 Sector average $1.46
▼
-97.4% below sector average
Key checks
Key Insights
- Dexcom's interest expense per share has declined for 4 consecutive years.
- In FY2025, interest expense per share decreased 2.6% year-over-year.
- Ranks #38 out of 44 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | -2.6% |
| FY2024 | $0.04 | -10.4% |
| FY2023 | $0.04 | -6.7% |
| FY2022 | $0.05 | -76.7% |
| FY2021 | $0.20 | +6.2% |
| FY2020 | $0.18 | -72.0% |
| FY2019 | $0.66 | +152.3% |
| FY2018 | $0.26 | +5418.4% |
| FY2017 | $0.00 | -51.7% |
| FY2016 | $0.01 | -15.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026